Capsule Filling Excipients

  • Check with publisher
  • Published date: March 23, 2021
    • United States

Formulationbio is a leading manufacturer of Lipid Excipients, serving the pharmaceutical industry to help it improve the performance of its products. We develop, produce and sell Film Former Excipients for solid, semi-solid and liquid dosage forms. Our excipients also include: binders, diluents, disintegrants, emulsifiers, lubricants, plasticizers, surfactants, sweeteners, stabilizers and so on. For more information, please visit the website: https://www.formulationbio.com/products/capsule-filling-excipients.html

Result 0 votes
Helen Smith
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Global Regulations for Equipment Qualification and Validation of Processes

    Global Regulations for Equipment Qualification and Validation of Processes

    Pharmacology - Drug Development san Jose (california) March 2, 2021 Check with publisher

    The various regulatory agencies have expectations that pharmaceutical manufacturers will demonstrate control over their manufacturing equipment. The FDA's findings of deficiencies concerning equipment validation indicate the agencies expect definitiv...

  • Ensuring Compliance with Advertising and Promotional Requirements for Drugs and Medical Devices

    Ensuring Compliance with Advertising and Promotional Requirements for Drugs and Medical Devices

    Pharmacology - Drug Development san Jose (california) March 2, 2021 Check with publisher

    Federal regulation of the advertising and promotion of pharmaceuticals and medical devices reflects an aggressive attitude on the part of the regulators that demands, in turn, that industry be keenly aware of the legal and regulatory duties, as well ...

  • Virtual Screening For Covalently Bound Drugs

    Virtual Screening For Covalently Bound Drugs

    Pharmacology - Drug Development (United States ) March 2, 2021 Check with publisher

    ComputaBio's overall solutions of virtual screening service for covalently bound drugs: 1. Valence pharmacophore model and fragment screening 2. Generation of a pharmacophore model 3. Validation of the pharmacophore model 4. 3D-Pharmacophore Virtual ...